MedTrace Logo

Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)

NCT02531607 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-02-05

No results posted yet for this study

Summary

This is a non-randomized natural history protocol in which patients undergoing surgery or endoscopy for suspected/ diagnosed pancreaticobiliary strictures are assigned to a) control (chronic pancreatitis, no pancreatic neoplasm, primary sclerosing cholangitis), b) non-carcinoma (bile duct stones, papillary stenosis, ), c) carcinoma non-pancreatic (ampullary and distal bile duct or cholangiocarcinoma) and d) pancreatic ductal adenocarcinoma (pancreatic cancer.

Conditions

  • Pancreatic Neoplasms

Interventions

OTHER

blood and bile

20ml of blood will be obtained from consented participants. 5ml of bile will be collected during the endoscopic procedure.

Sponsors & Collaborators

  • AdventHealth

    lead OTHER

Principal Investigators

  • Richard Pratley, MD · AdventHealth

Eligibility

Min Age
19 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-13
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02531607 on ClinicalTrials.gov